 |
|
|
| |
Evaluation of Potential Virologic Resistance in HBV Polymerase Among Subjects with Persistent Viremia Following
up to 144 Weeks of Therapy with Tenofovir DF
|
| |
| |
Reported by Jules Levin
EAS Apr 14-18 2010 Vienna Austria
A Snow-Lampart,1 B Chappell,1 J Sorbel,1 K Borroto-Esoda1 and M Miller2
1Gilead Sciences, Inc., Durham, NC, USA, 2Gilead Sciences, Inc., Foster City, CA, USA
Reference
1. Snow-Lampart et. al. AASLD 2009, Poster #480
|
| |
|
|
|
|
|
